|
|
|
|
LEADER |
01126nam a22002537a 4500 |
003 |
GR-PaULI |
005 |
20220204140150.0 |
007 |
ta |
008 |
220204s1984 ne ||||f |||| 10| 0 eng d |
952 |
|
|
|0 0
|1 0
|2 nlm
|4 0
|6 QV_89_NIM
|7 1
|9 355678
|a MEDI
|b MEDI
|c DON
|d 2022-02-04
|i 7584
|l 0
|o QV 89 NIM
|p 025000176549
|r 2022-02-04 00:00:00
|t 1
|w 2022-02-04
|y BKN
|z Δωρεά Π. Πολίτη (υπόγειο)
|
999 |
|
|
|c 208429
|d 208429
|
020 |
|
|
|a 902199643X
|
040 |
|
|
|a GR-PaULI
|b gre
|c GR-PaULI
|e AACR2
|
060 |
|
|
|a QV 89
|
100 |
1 |
|
|9 189957
|a Nimmo, Walter S.
|e επιμελητής
|
245 |
1 |
0 |
|a Opioid agonist/antagonist drugs in clinical practice :
|b proceedings of a symposium : Torquay - 28th September, 1983 /
|c editors W.S. Nimmo, G. Smith.
|
260 |
|
|
|a Amsterdam :
|b Excerpta Medica,
|c 1984.
|
300 |
|
|
|a x, 150 σ. ;
|c 24 εκ.
|
490 |
|
|
|a Current clinical practice series ;
|v 13
|
650 |
|
4 |
|9 86341
|a Οπιοειδή
|x Φυσιολογικές επιδράσεις
|
700 |
|
|
|9 189958
|a Smith, Graham,
|d 1941-
|e επιμελητής
|
830 |
|
0 |
|9 189959
|a Current clinical practice series
|v 13
|
942 |
|
|
|2 nlm
|c BKN
|
998 |
|
|
|c ΜΑΝΙΑΚΗ
|d 2022
|